Predictions
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€11.37
17.06.21
17.06.21
€18.00
09.03.22
09.03.22
95.60%
10.03.22
10.03.22
Could be very worthwhile Investment >20% year
Epizyme Inc.
Start price
Target price
Perf. (%)
€1.10
27.01.22
27.01.22
€1.00
27.01.23
27.01.23
41.00%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€2.84
05.01.21
05.01.21
€3.50
05.01.22
05.01.22
100.71%
06.01.22
06.01.22
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€46.03
04.01.21
04.01.21
€60.00
04.01.22
04.01.22
115.51%
05.01.22
05.01.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.32
28.12.20
28.12.20
€140.00
28.12.21
28.12.21
20.17%
29.12.21
29.12.21
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Amphastar Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€15.30
15.12.20
15.12.20
€18.00
15.12.21
15.12.21
28.10%
16.12.21
16.12.21
Dare Bioscience Inc.
Start price
Target price
Perf. (%)
€1.06
13.12.20
13.12.20
€1.20
13.12.21
13.12.21
47.17%
14.12.21
14.12.21
Ardelyx Inc.
Start price
Target price
Perf. (%)
€0.99
30.11.21
30.11.21
€1.00
30.11.22
30.11.22
36.36%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
Avid Bioservices Inc
Start price
Target price
Perf. (%)
€8.05
03.12.20
03.12.20
€9.00
03.12.21
03.12.21
200.62%
04.12.21
04.12.21
Invitae Corp
Start price
Target price
Perf. (%)
€20.09
09.11.21
09.11.21
€17.00
31.12.23
31.12.23
-23.92%
01.12.21
01.12.21
Could be very worthwhile Investment >20% year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€28.60
09.11.20
09.11.20
€20.00
09.11.21
09.11.21
-59.14%
10.11.21
10.11.21
Anavex Life Sciences Corp
Start price
Target price
Perf. (%)
€4.28
21.10.20
21.10.20
€6.00
04.11.21
04.11.21
348.60%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€14.20
16.10.20
16.10.20
€18.00
04.11.21
04.11.21
143.66%
05.11.21
05.11.21
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.20
14.10.20
14.10.20
€8.00
04.11.21
04.11.21
181.22%
05.11.21
05.11.21
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.96
10.10.20
10.10.20
€5.00
04.11.21
04.11.21
102.02%
05.11.21
05.11.21
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€32.80
02.10.20
02.10.20
€38.00
04.11.21
04.11.21
54.39%
05.11.21
05.11.21